|
|
 |
| Vaccine Policy and
Licensure |
|
| Recommendations of the Advisory Committee on
Immunization Practices |
|
Use of Anthrax Vaccine in Response
to Terrorism
Source: MMWR, November 15, 2002, Vol. 51(45):1024-1026 |
|
| HTML | PDF |
Use of Anthrax
Vaccine in the United States
Source: MMWR December 15, 2000 / Vol. 49 / No. RR-15 |
|
| HTML | PDF |
Prevention of Pertussis, Tetanus, and
Diphtheria Among Pregnant and Postpartum Women and Their Infants:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, May 14, 2008;57(Early
Release):1-47 |
|
|
HTML pt 1 |
HTML pt 2 |
HTML pt 3 |
PDF |
Preventing Tetanus,
Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced
Diphtheria Toxoid and Acellular Pertussis Vaccine
Please
note: If you are using the HTML version of this document, be sure to access
all four HTML links to get the complete content of the document,
which includes 3 important appendices.
Source:
MMWR, December 15, 2006;55(RR-17):1-33 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
Use of Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among
Adolescents
Please
note: If you are using the HTML version of this document, be sure to access
all the HTML links to get the complete content of the document,
which includes important appendices.
Source: MMWR, March
24, 2006, Vol. 55(RR03):1-49
|
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | HTML
pt.5 | HTML
pt.6 | HTML
pt.7 | PDF
(entire issue) |
Use of Diphtheria
Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose
Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13 |
|
| HTML | PDF |
Diphtheria,
Tetanus, and Pertussis, Recommendations for Vaccine Use and Other
Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10 |
|
| HTML | PDF |
| Recommendations
- Haemophilus influenzae type b (Hib) |
back
to top |
|
|
|
Interim Recommendations
for the Use of Haemophilus influenzae Type b (Hib) Conjugate Vaccines
Related to the Recall of Certain Lots of Hib-Containing Vaccines
(PedvaxHIB and Comvax)
Source: MMWR, December 19, 2007; 56(Dispatch):1-2 |
|
| HTML | PDF |
Use of Haemophilus
b Conjugate Vaccines and a Combined DTP and Hib Vaccine
Source: MMWR September 17, 1993 / Vol. 42 / No. RR-13 |
|
| HTML | PDF |
Haemophilus
b Conjugate Vaccines for Prevention of Hib Disease
Source: MMWR January 11, 1991 / Vol. 40 / No. RR-01 |
|
| HTML | PDF |
Update: Prevention
of Hepatitis A after Exposure to Hepatitis A Virus and in
International Travelers
Source: MMWR, October 19, 2007; 56(41):1080-1084 |
|
| HTML | PDF |
CDC Treatment Guidelines:
Sexually Transmitted Diseases, 2006
(Not an ACIP statement but an important document. Includes information
on hepatitis A, hepatitis B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, August 4, 2006, Vol. 55(RR11):1-94 |
|
| HTML | PDF |
Prevention of Hepatitis
A Through Active or Passive Immunization
Source: MMWR, May 19, 2006, Vol. 55(RR07):1-23 |
|
| HTML | PDF |
Correctional Settings: Prevention and
Control of Infections with Hepatitis Viruses in Correctional Settings
(not an ACIP statement but an important document)
Source: MMWR, January 24, 2003, Vol. 52(RR-1):1-44 |
|
| HTML | PDF |
A Comprehensive Immunization
Strategy to Eliminate Transmission of Hepatitis B Virus Infection
in the United States. Part II: Immunization of Adults
Please note: If you are using
the HTML version of this document, be sure to access all four
HTML links to get the complete content of the document, which
includes 3 important appendices.
Source:
MMWR, December 8, 2006;55(RR-16):1-25R |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
CDC Treatment Guidelines:
Sexually Transmitted Diseases, 2006
(Not an ACIP statement but an important document. Includes information
on hepatitis A, hepatitis B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, August 4, 2006, Vol. 55(RR11):1-94 |
|
| HTML | PDF |
A Comprehensive Immunization
Strategy to Eliminate Transmission of Hepatitis B Virus Infection
in the United States. Part 1: Immunization of Infants, Children
and Adolescents.
Please note: If you are using the HTML version of this document, be sure
to access all four HTML links to get the complete content of the document,
which includes 3 important appendices.
Source: MMWR, December
23, 2005, Vol. 54(RR-16):1-39 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
A Comprehensive Immunization
Strategy to Eliminate Transmission of Hepatitis B Virus Infection
in the United States. Part II: Immunization of Adults
Please note: If you are using
the HTML version of this document, be sure to access all four
HTML links to get the complete content of the document, which
includes 3 important appendices.
Source:
MMWR, December 8, 2006;55(RR-16):1-25R |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
Correctional Settings: Prevention and
Control of Infections with Hepatitis Viruses in Correctional Settings
(not an ACIP statement but an important document)
Source: MMWR, January 24, 2003, Vol. 52(RR-1):1-44 |
|
| HTML | PDF |
Management of
Occupational Exposures to HBV, HCV, and HIV and Recommendations
for Postexposure Prophylaxis
(not an ACIP statement but an important update document)
Source: MMWR June 29, 2001 / Vol. 50 / No. RR-11 |
|
| HTML | PDF |
Recommendations
for Preventing Transmission of Human Immunodeficiency Virus and
Hepatitis B Virus to Patients During Exposure-Prone Invasive Procedures
(not an ACIP statement but an important document)
Source: MMWR, July 12, 1991 / Vol. 40 / No. RR08 |
|
| HTML | PDF |
| Recommendations
- Human papillomavirus
(HPV)
|
back
to top |
|
|
|
Quadrivalent
Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24 |
|
| HTML | PDF |
CDC Treatment Guidelines:
Sexually Transmitted Diseases, 2006
(Not an ACIP statement but an important document. Includes information
on hepatitis A, hepatitis B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, August 4, 2006, Vol. 55(RR11):1-94 |
|
| HTML | PDF |
ACIP Provisional Recommendations for
the Prevention and Control of Influenza (2008-2009 influenza season)
Source: Centers for Disease Control and Prevention, March 21, 2008 |
|
|
PDF |
Expansion of Use of Live Attenuated
Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other
FluMist Changes for the 2007--08 Influenza Season
Source: MMWR, November
23, 2007; 56(46):1217-1219 |
|
| HTML | PDF |
Prevention and
Control of Influenza
Source: MMWR, July 13, 2007; 56(RR06):1-54 |
|
| HTML | PDF |
Influenza Vaccination
of Health-Care Personnel
Source: MMWR, February 24, 2006, Vol. 55(RR02):1-16 |
|
| HTML | PDF |
Using Live, Attenuated Influenza Vaccine
for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB) |
|
| HTML | PDF |
Inactivated
Japanese Encephalitis Virus Vaccine
Source: MMWR January 8, 1993/ Vol. 42/ No. RR-1 |
|
| HTML | PDF |
ACIP Recommendations: Update Regarding
Administration of Combination MMRV Vaccine
MMWR, March 14, 2008 / 57(10);258-260 |
|
|
HTML | PDF |
Measles, Mumps,
and Rubella--Vaccine Use and Strategies
Source: MMWR May 22, 1998 / Vol. 47 / No. RR-8 |
|
| HTML | PDF |
ACIP Recommendations: Update Regarding
Administration of Combination MMRV Vaccine
MMWR, March 14, 2008 / 57(10);258-260 |
|
|
HTML | PDF |
Control and Elimination
of Mumps
Source: MMWR, June 9, 2006, Vol. 55(22):629-630 |
|
| HTML | PDF |
Measles, Mumps,
and Rubella--Vaccine Use and Strategies
Source: MMWR May 22, 1998 / Vol. 47 / No. RR-8 |
|
| HTML | PDF |
Recommendation
from the Advisory Committee on Immunization Practices (ACIP) for
Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children
Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, December 7, 2007; 56(48):1265-1266 |
|
| HTML | PDF |
Revised Recommendations
of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal
Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795 |
|
| HTML | PDF |
Prevention and Control of Meningococcal
Disease
Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21 |
|
| HTML | PDF |
Prevention of
Plague
Source: MMWR December 13, 1996 / Vol. 45 / No. RR-14 |
|
| HTML | PDF |
Prevention of Pertussis, Tetanus, and
Diphtheria Among Pregnant and Postpartum Women and Their Infants:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, May 14, 2008;57(Early
Release):1-47 |
|
|
HTML pt 1 |
HTML pt 2 |
HTML pt 3 |
PDF |
Preventing Tetanus,
Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced
Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this
document, be sure to access all four HTML links to get the complete content
of the document,
which includes 3 important appendices.
Source: MMWR, December
15, 2006;55(RR-17):1-33 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
Use of Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among
Adolescents
Please note: If you are using the HTML version of this document, be sure
to access all the HTML links to get the complete content of the document,
which includes important appendices.
Source:
MMWR, March 24, 2006, Vol. 55(RR03):1-49 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | HTML
pt.5 | HTML
pt.6 | HTML
pt.7 | PDF
(entire issue) |
CDC
Treatment Guidelines: Recommended Antimicrobial Agents for the Treatment
and Postexposure Prophylaxis of Pertussis
(not an ACIP statement but a recommendation from NIP, CDC)
Source: MMWR, December 9, 2005, Vol. 54(RR14):1-16 |
|
| HTML | PDF |
Use of Diphtheria
Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose
Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13 |
|
| HTML | PDF |
Use of Acellular
Pertussis Vaccines
Source: MMWR March 28, 1997 / Vol. 46 / No. RR-7 |
|
| HTML | PDF |
Diphtheria,
Tetanus, and Pertussis, Recommendations for Vaccine Use and Other
Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10 |
|
| HTML | PDF |
Updated Recommendation from the
Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent
Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who
Are Not Completely Vaccinated
Source: MMWR, April 4, 2008; 57(13):343-344 |
|
|
HTML | PDF |
Pneumococcal Vaccination for Cochlear
Implant Candidates and Recipients
Source: MMWR, Early Release, July 31, 2003, Vol. 52;1-2 |
|
| HTML | PDF |
Preventing
Pneumococcal Disease Among Infants and Young Children
Source: MMWR
October 6, 2000 / Vol. 49 / No. RR-09 |
|
| HTML | PDF |
Prevention of
Pneumococcal Disease
Source: MMWR April 04, 1997 / Vol. 46 / No. RR-08 |
|
| HTML | PDF |
Poliomyelitis
Prevention in the United States
Source: MMWR May 19, 2000 / Vol. 49 / No. RR-05 |
|
| HTML | PDF |
Human Rabies Prevention--United
States, 2008: Recommendations of the Advisory Committee on Immunization
Practices
MMWR, May 7, 2008;57(Early Release):1-26,28 |
|
|
HTML pt 1 |
HTML pt 2 | PDF |
| ACIP Provisional Recommendations for
the Prevention of Rotavirus Gastroenteritis among Infants and Children,
July 1, 2008 |
|
| HTML | PDF |
ACIP Recommendations: Update Regarding
Administration of Combination MMRV Vaccine
MMWR, March 14, 2008 / 57(10);258-260 |
|
|
HTML | PDF |
CDC Guidelines:
Evaluation and Management of Suspected Outbreaks, Rubella in Pregnant
Women, and Surveillance for Congenital Rubella Syndrome
(not an ACIP statement but an important update document)
Source: MMWR July 13, 2001 / Vol. 50 / No. RR-12 |
|
| HTML | PDF |
Measles, Mumps,
and Rubella--Vaccine Use and Strategies
Source: MMWR May 22, 1998 / Vol. 47 / No. RR-8 |
|
| HTML | PDF |
Prevention of Herpes Zoster:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source:
MMWR, May 15, 2008; 57(Early Release):1-30 |
|
|
HTML | PDF |
Recommendations for Using Smallpox
Vaccine in a Pre-Event Vaccination Program
Source: MMWR, Recommendations and Reports, April 4, 2003, Vol. 52(RR-7) |
|
| HTML | PDF |
Vaccinia (Smallpox)
Vaccine
Source: MMWR June 22, 2001 / Vol. 50 / No. RR-10 |
|
| HTML | PDF |
Prevention of Pertussis, Tetanus, and
Diphtheria Among Pregnant and Postpartum Women and Their Infants:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, May 14, 2008;57(Early
Release):1-47 |
|
|
HTML pt 1 |
HTML pt 2 |
HTML pt 3 |
PDF |
Preventing Tetanus,
Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced
Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this
document, be sure to access all four HTML links to get the complete content
of the document,
which includes 3 important appendices.
Source: MMWR, December 15,
2006;55(RR-17):1-33 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
Use of Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among
Adolescents
Please note: If you are using the HTML version
of this document, be sure to access all the HTML links to get the
complete content of the document,
which includes important appendices.
Source:
MMWR, March 24, 2006, Vol. 55(RR03):1-49 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | HTML
pt.5 | HTML
pt.6 | HTML
pt.7 | PDF
(entire issue) |
Use of Diphtheria
Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose
Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13 |
|
| HTML | PDF |
Diphtheria,
Tetanus, and Pertussis, Recommendations for Vaccine Use and Other
Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10 |
|
| HTML | PDF |
| |
IAC Home